Loading
DH
Diagnamed Holdings Corp. Stock: price and insider trades · Canada
Diagnamed Holdings Corp.: what insiders have been doing
Diagnamed Holdings Corp. is a listed company. Its directors and officers file their transactions with SEDI. Between 18 October 2025 and 18 October 2026, 1 insider published 3 filings.
Every open-market trade in the period is a purchase: 3 purchases worth €16k, from 1 insider, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 senior executive. Biggest ticket of the year: €9,358, bought by Karagiannidis, John Ioannis and made public on 24 July 2026.
The last insider purchase was made public on 24 July 2026, 85 days ago. Filings reach the SEDI feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade.
With 3 filings in twelve months, the company is quieter than the median of 12 filings across the 2,120 companies we follow on the same exchange. Looking back to 2026, when coverage begins, insiders filed 3 purchases and no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€15,597
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJohn Ioannis Karagiannidis3 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
CA$0.04
Last declaration on 24 July 2026
Declarations3 total
250,000 shares@ CA$0.0660.0% of flowCommon SharesTSXSEDI:4755559
Canonical exit: 21 Oct 2026 (T+90)
100,000 shares@ CA$0.06526.0% of flowCommon SharesTSXSEDI:4755558
Canonical exit: 21 Oct 2026 (T+90)
50,000 shares@ CA$0.0714.0% of flowCommon SharesTSXSEDI:4755557
Canonical exit: 21 Oct 2026 (T+90)
3 of 3 declarations
About Diagnamed Holdings Corp.
Diagnamed Holdings Corp. is a company listed on the Toronto Stock Exchange, specializing in the development of medical diagnostic solutions. It focuses on innovation in the healthcare sector to improve patient outcomes.
